AAAAAA
Results:
1-14
|
Results: 14
Authors:
LISSNER R
THURMANN PA
MERZ G
KARCH H
Citation: R. Lissner et al., ANTIBODY REACTIVITY AND FECAL RECOVERY OF BOVINE IMMUNOGLOBULINS FOLLOWING ORAL-ADMINISTRATION OF A COLOSTRUM CONCENTRATE FROM COWS (LACTOBIN) TO HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 239-245
Authors:
BITZAN MM
GOLD BD
PHILPOTT DJ
HUESCA M
SHERMAN PM
KARCH H
LISSNER R
LINGWOOD CA
KARMALI MA
Citation: Mm. Bitzan et al., INHIBITION OF HELICOBACTER-PYLORI AND HELICOBACTER-MUSTELAE BINDING TO LIPID RECEPTORS BY BOVINE COLOSTRUM, The Journal of infectious diseases, 177(4), 1998, pp. 955-961
Authors:
SCHRODER W
LISSNER R
BENDER HG
Citation: W. Schroder et al., INTRAPERITONEAL THERAPY WITH INTERLEUKIN-2 (NIL-2) IN PATIENTS WITH OVARIAN-CARCINOMA PRECLINICAL AND CLINICAL-RESULTS, European journal of cancer, 33, 1997, pp. 68-68
Authors:
KARCH H
HUPPERTZ HI
BOCKEMUHL J
SCHMIDT H
SCHWARZKOPF A
LISSNER R
Citation: H. Karch et al., SHIGA TOXIN-PRODUCING ESCHERICHIA-COLI INFECTIONS IN GERMANY, Journal of food protection, 60(11), 1997, pp. 1454-1457
Authors:
LORENZ J
WILHELM K
KESSLER M
PESCHEL C
SCHWULERA U
LISSNER R
STRUFF WG
HULAND E
HUBER C
AULITZKY WE
Citation: J. Lorenz et al., PHASE-I TRIAL OF INHALED NATURAL INTERLEUKIN-2 FOR TREATMENT OF PULMONARY MALIGNANCY - TOXICITY, PHARMACOKINETICS, AND BIOLOGICAL EFFECTS, Clinical cancer research, 2(7), 1996, pp. 1115-1122
Authors:
LISSNER R
Citation: R. Lissner, H-SUBSTANCE AS A CARRIER SYSTEM FOR THE A BO ANTIGENS - A DIAGNOSTIC-TOOL IN CLINICAL MEDICINE AND ITS CONCEIVABLE USE FOR CANCER-THERAPY, Infusionstherapie und Transfusionsmedizin, 23(6), 1996, pp. 262
Authors:
MEYER T
SCHOLZ D
WARNECKE G
KUNZ M
ARNDT R
REISCHL U
WOLF H
LISSNER R
Citation: T. Meyer et al., IMPORTANCE OF SIMULTANEOUS ACTIVE CYTOMEGALOVIRUS AND EPSTEIN-BARR-VIRUS INFECTION IN RENAL-TRANSPLANTATION, Clinical and diagnostic virology, 6(2-3), 1996, pp. 79-91
Authors:
LISSNER R
SCHMIDT H
KARCH H
Citation: R. Lissner et al., A STANDARD IMMUNOGLOBULIN PREPARATION PRODUCED FROM BOVINE COLOSTRA SHOWS ANTIBODY REACTIVITY AND NEUTRALIZATION ACTIVITY AGAINST SHIGA-LIKE TOXINS AND EHEC-HEMOLYSIN OF ESCHERICHIA-COLI O157-H7, Infection, 24(5), 1996, pp. 378-383
Authors:
SCHERBERICH JE
LISSNER R
KACHEL HG
SCHEUERMANN E
Citation: Je. Scherberich et al., IMMUNOGLOBULIN SUBCLASS DEFICIENCY AND AL TERED EXPRESSION OF MONOCYTE LPS-RECEPTOR CD14 IN RENAL GRAFT RECIPIENTS - ASSOCIATION WITH CHRONIC URINARY-TRACT INFECTION, Nieren- und Hochdruckkrankheiten, 25(11), 1996, pp. 545-548
Authors:
SCHRODER W
SCHWULERA U
LISSNER R
BENDER HG
Citation: W. Schroder et al., EXPERIMENTAL, PHARMAKOKINETIC AND CLINICA L-EVALUATION OF IP THERAPY WITH INTERLEUKIN-2 (NIL-2) IN PATIENTS WITH OVARIAN-CANCER, Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 46-52
Authors:
AUTENRIETH IB
SCHWARZKOPF A
EWALD JH
KARCH H
LISSNER R
Citation: Ib. Autenrieth et al., BACTERICIDAL PROPERTIES OF CAMPYLOBACTER JEJUNI-SPECIFIC IMMUNOGLOBULIN-M ANTIBODIES IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1965-1969
Authors:
THURMANN PA
SONNENBURGCHATZOPOULOS C
LISSNER R
Citation: Pa. Thurmann et al., PHARMACOKINETIC CHARACTERISTICS AND TOLERABILITY OF A NOVEL INTRAVENOUS IMMUNOGLOBULIN PREPARATION, European Journal of Clinical Pharmacology, 49(3), 1995, pp. 237-242
Authors:
ROSENER M
SCHWULERA U
MENKE G
THRUN A
LISSNER R
KRAUSENECK P
BOGDAHN U
MARTIN R
Citation: M. Rosener et al., TOLERANCE AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF INTRATHECALLY ADMINISTERED HUMAN NATURAL INTERLEUKIN-2 - A PHASE-I TRIAL, European cytokine network, 4(3), 1993, pp. 189-195
Authors:
SCHRODER W
DONNERSTAG B
LISSNER R
BENDER HG
Citation: W. Schroder et al., CYTOTOXICITY TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITES AND PLEURAL EXUDATE OF PATIENTS WITH OVARIAN OR BREAST-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1102-1103
Risultati:
1-14
|